Navigation Links
Pressure BioSciences, Inc. Announces Move to New Corporate Offices
Date:3/10/2008

SOUTH EASTON, Mass., March 10 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that it has moved its corporate offices to 14 Norfolk Avenue in South Easton, Massachusetts. This move was necessary to accommodate the Company's transition from an early-stage, research and development company to a fully commercial operation. Richard T. Schumacher, PBI's Founder, President, and CEO commented: "We now have approximately 5,500 square feet, with sufficient office, conference, engineering lab, and storage space to allow us to better develop our infrastructure to support our PCT product commercialization. In addition, the 18 month lease, with equal term extension, gives us the financial flexibility we require as we continue to grow our business and carefully manage our financial resources". The Company's primary research and development facility continues to be located at 6 Gill Street in Woburn, MA.

Corporate address:

Pressure BioSciences, Inc

14 Norfolk Avenue

South Easton, MA 02375

(t) (508) 230-1828

(f) (508) 230-1829

Research and Development Center

Pressure BioSciences, Inc

6 Gill Street, Suite H

Woburn, MA 01801

(t) (781) 932-9477

(f) (781) 932-9294

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

Visit us at our website http://www.pressurebiosciences.com

Investor Contacts:

Richard T. Schumacher, President & CEO Pressure BioSciences, Inc.

Edward H. Myles,

Senior Vice President of Finance & CFO (T) 508-230-1828


'/>"/>
SOURCE Pressure BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Specific antagonism lowers blood pressure
3. Doctors Often Miss High Blood Pressure in Kids
4. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
5. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
6. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio
7. AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure
8. Memory tasks require more coordinated brain blood flow for people with high blood pressure
9. Pressure to Promote Healthier Eating to Cause Minor Growing Pains for Kids Licensed Foods and Beverages
10. High Blood Pressure & Stroke Attack was the Focus for the Third Stop of the 2007 Empowerment Tour for a Healthier Life
11. Daytime, Nighttime Blood Pressure Both Important
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... ... ... Since PermaLip™ implants are solid, patients do not have to worry ... a natural look. “I always double and triple check implant placement to ensure that ... Dr. Jessica Kulak, double board certified facial plastic surgeon at The Naderi Center for ...
(Date:12/5/2018)... ... ... Dr. Jessica Allen of Northern Colorado Periodontics is pleased to offer the ... the Fort Collins area. Dr. Allen joins an elite class of periodontists providing ... to gum disease. , "Gum disease is a problem that many people have, and ...
(Date:12/5/2018)... Okla. (PRWEB) , ... December 04, 2018 , ... ... open on January 1st, 2019 at 16 E 4th Street. , The dispensary ... marijuana license. Earthly Mist staff will work with patients to find the correct ...
(Date:11/29/2018)... ... November 29, 2018 , ... ... alleviate and treat chronic pain without opiates. This new and unique approach to ... or eliminate chronic pain for both children and adults. , According to ...
(Date:11/29/2018)... ... November 29, 2018 , ... “The total demand for technologies used ... President of Business Intelligence at SDi. “We project the market will grow at a ... for novel drugs as the global population ages.” , This report details market activity ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... ... November 29, 2018 , ... ... product makes the company’s powerful electronic forms and eSignatures functionality accessible via tablets, ... leaps and bounds in the consumer space and it’s about time hospital solutions ...
(Date:11/28/2018)... ... November 28, 2018 , ... CME Outfitters (CMEO), a ... partnership with CME Master, a division of HealthMinds Consulting Pvt. Ltd. to bring ... East Asia expected soon. This new collaboration will provide access to top-of-the-line, convenient, ...
(Date:11/28/2018)... ... November 28, 2018 , ... All-star NBA player ... Tel HaShomer this week to form a collaboration between the hospital’s global humanitarian ... Republic of Congo. , On Thursday, November 29, Dikembe Mutombo will spend ...
Breaking Medicine Technology: